We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+8.17%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$19.4B
AUM Growth
-$763M
Cap. Flow
-$1.22B
Cap. Flow %
-6.3%
Top 10 Hldgs %
44.78%
Holding
3,509
New
1,167
Increased
475
Reduced
708
Closed
1,145

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$349M
2
CVX icon
Chevron
CVX
+$242M
3
APP icon
Applovin
APP
+$223M
4
META icon
Meta Platforms (Facebook)
META
+$217M
5
GEV icon
GE Vernova
GEV
+$146M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$883M
2
MSFT icon
Microsoft
MSFT
+$533M
3
NVDA icon
NVIDIA
NVDA
+$459M
4
LLY icon
Eli Lilly
LLY
+$167M
5
PCG icon
PG&E
PCG
+$153M

Sector Composition

Rank Sector Weight
1 Technology 10.04%
2 Financials 6.81%
3 Communication Services 6.52%
4 Industrials 5.9%
5 Consumer Discretionary 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERU icon
2201
Veru
VERU
$37.4M
$21K ﹤0.01%
+3,365
New +$25K
BNBX
2202
DELISTED
BNB PLUS CORP
BNBX
$20K ﹤0.01%
+135
New +$23.5K
EMX
2203
DELISTED
EMX Royalty
EMX
$20K ﹤0.01%
+12,060
New +$21.6K
LGVN
2204
Longeveron
LGVN
$24.2M
$20K ﹤0.01%
+11,681
New +$23K
ZONE
2205
CleanCore Solutions
ZONE
$81.5M
$20K ﹤0.01%
+16,234
New +$23.8K
NAKA
2206
Nakamoto Inc
NAKA
$86.7M
$20K ﹤0.01%
+414
New +$19.1K
SYRS
2207
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$20K ﹤0.01%
+87,535
New +$105K
ALEC icon
2208
Alector
ALEC
$199M
$19K ﹤0.01%
10,346
-39,017
-79% -$147K
AUUD
2209
Auddia
AUUD
$4.41M
$19K ﹤0.01%
299
+58
+24% +$4.41K
ENLV icon
2210
Enlivex Ltd
ENLV
$35M
$19K ﹤0.01%
+1,125
New +$21.9K
JCSE icon
2211
JE Cleantech Holdings
JCSE
$7.61M
$19K ﹤0.01%
+14,556
New +$19.9K
LVO icon
2212
LiveOne
LVO
$58.2M
$19K ﹤0.01%
+1,350
New +$11.8K
MGIH icon
2213
Millennium Group International
MGIH
$17.2M
$19K ﹤0.01%
+12,734
New +$21K
VBIO
2214
Valion Bio
VBIO
$1.18M
$19K ﹤0.01%
+3,450
New +$16.1K
TPET icon
2215
Trio Petroleum
TPET
$10.4M
$19K ﹤0.01%
+16,473
New +$32.8K
WETH icon
2216
Wetouch Technology
WETH
$12.6M
$19K ﹤0.01%
+11,021
New +$19.5K
BOF icon
2217
BranchOut Food
BOF
$63.6M
$18K ﹤0.01%
+10,829
New +$18.6K
CLDI icon
2218
Calidi Biotherapeutics
CLDI
$3.96M
$18K ﹤0.01%
+82
New +$24.6K
CNSP icon
2219
CNS Pharmaceuticals
CNSP
$7.86M
$18K ﹤0.01%
+260
New +$18.5K
FRGT icon
2220
Freight Technologies
FRGT
$1.57M
$18K ﹤0.01%
+100
New +$17.1K
IMNN icon
2221
Imunon
IMNN
$6.77M
$18K ﹤0.01%
+1,473
New +$17K
NFGC
2222
New Found Gold
NFGC
$641M
$18K ﹤0.01%
+10,154
New +$20.7K
PTN
2223
Palatin Technologies
PTN
$13.8M
$18K ﹤0.01%
+336
New +$17K
QNRX
2224
Quoin Pharmaceuticals
QNRX
$9.62M
$18K ﹤0.01%
+792
New +$18.2K
THTX
2225
DELISTED
Theratechnologies
THTX
$18K ﹤0.01%
+10,185
New +$13.8K

Similar funds

HRT Financial's Q4 2024 Portfolio in Review

As of Q4 2024, HRT Financial held 3,509 positions worth $19.4B, down 3.8% from $20.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

HRT Financial withdrew a net $1.22B in Q4 2024, closing 1,145 positions and reducing 708 holdings. Its most notable exit was PG&E, an estimated $153M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Communication Services.

Against the trend, HRT Financial opened a new position in Broadcom worth $437M.

  • HRT Financial's largest Q4 2024 buy was Broadcom: 1,884,640 shares worth $437M.
  • HRT Financial added most to Meta Platforms (Facebook) in Q4 2024, an estimated $217M increase.
  • HRT Financial's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $883M.
  • HRT Financial fully exited PG&E in Q4 2024, selling an estimated $153M.
  • HRT Financial's ten largest holdings make up 45% of its $19.4B portfolio in Q4 2024.
  • HRT Financial opened 1,167 new positions and closed 1,145 in Q4 2024.
  • HRT Financial's portfolio value fell 3.8% quarter-over-quarter to $19.4B.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.